Skip to main content
Premium Trial:

Request an Annual Quote

Epistem, GSK Partner to Better Understand Fibrosis

NEW YORK (GenomeWeb News) – Epistem today announced a research collaboration with GlaxoSmithKline to use its amplification technology to gain a better understanding of fibrosis.

The Manchester, UK-based firm will use its RNA-Amp technology to identify characteristics of diseased fibrotic tissue, Epistem said. The deal is for three years, but further terms were not disclosed.

Epistem's RNA-Amp technology provides gene expression information from small tissue samples and low number of cells, such as those from cells at the base of a single hair follicle or laser captured microdissected samples, it said.

Last week, Epistem said it had reached a deal with Xcelris Labs of India for the sales and marketing of its rapid molecular tuberculosis diagnostic test.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.